News Stay tuned and learn Genekor’s latest news and updates on Molecular Oncology. 29.11.2021 A documentary by Daphne Karavokyri about hereditary cancer Daphne Karavokyri shares her new documentary on Hereditary Cancer and the HerediGene genetic test she undertook at Genekor. read more 30.08.2021 Article at THE DOCTOR Magazine: NGS PLATFORM - ITS CONTRIBUTION TO CLINICAL PRACTICE Ποιά η συμβολή της πλατφόρμας NGS στη μάχη κατά του καρκίνου Article in "The Doctor" magazine by members of the scientific research team of hereditary cancer of Genekor Medical. They write: Konstantinos Agiannitopoulos Molecular Biologist, MSc, PhD & Despina Apostolopoulou Molecular Biologist, MSc, PhD read more 28.04.2021 FORBES: THE COMPANY THAT EVOLVED INTO ONE OF THE LEADING BIOTECHNOLOGY LAB NETWORK IN EUROPE Today Genekor is at the front line of modern medicine. read more 11.12.2020 SABCS - RxPONDER TRIAL Study RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer. read more 29.07.2020 Surviving Cancer - Elena's Story Elena is sharing with us her story. read more 09.07.2020 Surviving Cancer - Elsa's Story The story of surviving cancer through the eyes of a young woman named Elsa. read more 18.06.2020 The New Molecular Assay by Genekor Medical S.A. - PrIMe. PrIMe assay is a 500+ Gene panel- test that also analyses immunotherapy biomarkers MSI, TMB and PD-L1. It is one of the most detailed, sensitive and specific tests for the tumor biology configuration, enabling physicians to plan an efficient targeted treatment plan for the patient, including immuotherapies. read more 18.06.2020 The FDA has approved the use of TMB (Tumor Mutation Burden) detection as a biomarker. The FDA has approved the use of TMB (Tumor Mutation Burden) detection as a biomarker for the selection of pembrolizumab (Keytruda™) as a treatment for adults and pediatric patients with incurable or metastatic solid tumors. read more 11.06.2020 Choosing my medication based on my DNA? A new molecular test, called MyTheragene, which is performed once in our lives and based on the science of pharmacogenomics, provides the answers between 500 different drugs, making it easier for the doctor and patient to choose a safe, individualized and effective treatment with obvious benefits for the patient. read more 1 2 3 About Contact us © 2017 GENEKOR MEDICAL S.A. All rights reserved | Terms of Use | Secure Transactions | Sitemap Committed to biotechnological innovation Change cookies consent Revoke cookies consent